Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
Hendrix
Carolyn
C
Hoag Cancer Center, Newport Beach, CA, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000628:therapy*; D009367:Neoplasm Staging; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D016499:Radioimmunotherapy; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000069283:Rituximab; C422802:ibritumomab tiuxetan; C119496:tositumomab I-131